Literature DB >> 11771632

WMS-III performance in patients with temporal lobe epilepsy: group differences and individual classification.

N Wilde1, E Strauss, G J Chelune, D W Loring, R C Martin, B P Hermann, E Sherman, M Hunter.   

Abstract

The utility of the WMS-III in detecting lateralized impairment was examined in a large sample of patients with temporal lobe epilepsy. Methods of analysis included evaluation of group means on the various indexes and subtest scores, the use of ROC curves, and an examination of Auditory-Visual Index discrepancy scores. In addition, performance on immediate and delayed indexes in the auditory and the visual modality was compared within each group. Of the WMS-III scores, the Auditory-Visual Delayed Index difference score appeared most sensitive to side of temporal dysfunction, although patient classification rates were not within an acceptable range to have clinical utility. The ability to predict laterality based on statistically significant index score differences was particularly weak for those with left temporal dysfunction. The use of unusually large discrepancies led to improved prediction, however, the rarity of such scores in this population limits their usefulness. Although the utility of the WMS-III in detecting laterality may be limited in preoperative cases, the WMS-III may still hold considerable promise as a measure of memory in documenting baseline performance and in detecting those that may be at risk following surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11771632

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  13 in total

Review 1.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

2.  History of neuropsychology through epilepsy eyes.

Authors:  David W Loring
Journal:  Arch Clin Neuropsychol       Date:  2010-04-15       Impact factor: 2.813

3.  Temporal lobe epilepsy and the selective reminding test: the conventional 30-minute delay suffices.

Authors:  Brian D Bell; Jason Fine; Christian Dow; Michael Seidenberg; Bruce P Hermann
Journal:  Psychol Assess       Date:  2005-03

4.  Significant discrepancies between immediate and delayed WMS-III indices are rare in temporal lobe epilepsy patients.

Authors:  Brian D Bell; Bruce P Hermann; Michael Seidenberg
Journal:  Clin Neuropsychol       Date:  2004-05       Impact factor: 3.535

Review 5.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

6.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

7.  Route learning impairment in temporal lobe epilepsy.

Authors:  Brian D Bell
Journal:  Epilepsy Behav       Date:  2012-10-04       Impact factor: 2.937

8.  Detecting differential memory performance among Spanish-speaking patients with temporal lobe epilepsy.

Authors:  C Marquez de la Plata; L H Lacritz; R Mitschke; P Van Ness; M Agostini; R Diaz-Arrastia; C M Cullum
Journal:  NeuroRehabilitation       Date:  2009       Impact factor: 2.138

9.  Wechsler Memory Scale-III Faces test performance in patients with mild cognitive impairment and mild Alzheimer's disease.

Authors:  Adriana M Seelye; Diane B Howieson; Katherine V Wild; Mindy Milar Moore; Jeffrey A Kaye
Journal:  J Clin Exp Neuropsychol       Date:  2008-11-26       Impact factor: 2.475

10.  Cognitive impairments in patients with intractable temporal lobe epilepsy.

Authors:  Mahgol Tavakoli; Majid Barekatain; Hamid Taher Neshat Doust; Hossein Molavi; Reza Kormi Nouri; Alireza Moradi; Jafar Mehvari; Mohammad Zare
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.